Life Sciences 

 
 

Bird & Bird is recognised as the leading international law firm for Life Sciences, offering Corporate, Commercial, Regulatory and Intellectual Property advice to some of the world’s most innovative and dynamic organisations in the Life Sciences sector.

Building on the scientific or technical backgrounds which many of our Life Sciences lawyers possess, our practice is centred around Pharmaceutical, Biotech, Healthcare and Medical Device businesses, drawing not only on our market-leading IP expertise but equally focused on Corporate, Commercial, Regulatory, Competition and Dispute Resolution services.

We advise at every phase of the growth cycle: from university spin-outs to global giants, helping to organise early-stage formation and financing as well as handling technology transfers, IP licensing, Regulatory and Competition Law issues. We also provide transactional support to businesses following a dynamic growth path through innovative deal structures involving for example pipeline acquisitions, collaborations, strategic alliances, private equity involvements, M&A or market listings.

For both new and established ventures, we routinely advise on R&D collaborations, marketing arrangements, clinical trials, trademark and patent disputes and product liability. Many of our instructions are multi-jurisdictional and involve both project management expertise and close collaboration with other offices.


Heads of Group: Trevor Cook & Massimiliano Mostardini

News & Updates

Press Releases

Bird & Bird strengthens its energy, clean tech and climate change team

11-11-2011

Bird & Bird is delighted to announce the arrival of Helen Loose to our International Energy and Utilities Sector Group and International Commercial Practice Group.  Helen’s arrival will boost our
Bird & Bird wins multiple awards in the international Who's Who Legal Awards 2011

21-06-2011

- Bird & Bird has been named Global Firm of the Year in the Who's Who Legal Awards 2011 in four categories. - We have held the Global Firm for

Our Lawyers in Print

Articles

Know Your Rights

September, 2011

A medicinal product’s rights are not necessarily limited to patent protection and its extension. In order to obtain marketing authorisation for a medicinal product, a registration dossier must be submitted
Court of Justice judgments in Synthon and Generics SPC references

July, 2011

On 28 July 2011, the Court of Justice of the European Union handed down its decision in Synthon v Merz (C-195/09) and Generics v Synaptech (C-427/09). - Summary - The
 
 
Sharpen Your Focus
Expertise by sector, service and location. Select a single option, or a combination of any 2 options
 
select
 
select
 
select
 
Download Brochure
Life Sciences Brochure (pdf)
The Bribery act find out the latest information and how it will affect your organisation.
 
 
Author: Sword-UK - SharePoint Solutions